New China Life Insurance Co (FRA:NCL) YoY EBITDA Growth: 46.24% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NCL New China Life Insurance Co Ltd FRA:NCL
69 GF Score
Price €5.15
GF Value €4.61
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is New China Life Insurance Co YoY EBITDA Growth?

New China Life Insurance Co FRA:NCL +1.96% 69 YoY EBITDA Growth is 46.24% as of Jun. 2026. GuruFocus rates FRA:NCL with a GF Score™ of 69/100 and a GF Value™ of €4.61 (Modestly Overvalued). The stock has 2 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. New China Life Insurance Co's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 46.24%.

New China Life Insurance Co's EBITDA per Share for the six months ended in Jun. 2026 was €1.09.

New China Life Insurance Co YoY EBITDA Growth Related Terms

New China Life Insurance Co YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for New China Life Insurance Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New China Life Insurance Co YoY EBITDA Growth Chart

New China Life Insurance Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.21 51.73 -62.84 216.98 18.16

New China Life Insurance Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.41 975.28 31.68 7.96 46.24
FRA:NCL
69GF Score
New China Life Insurance Co Ltd FRA:NCL
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New China Life Insurance Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

New China Life Insurance Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(1.588-1.344)/ | 1.344 |
=18.15 %

New China Life Insurance Co's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(1.088-0.744)/ | 0.744 |
=46.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 46.24% mean?
New China Life Insurance Co (FRA:NCL) has a YoY EBITDA Growth of 46.24% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for New China Life Insurance Co and its competitors.
Is New China Life Insurance Co's YoY EBITDA Growth too high?
New China Life Insurance Co's current YoY EBITDA Growth is 46.24%. Overall, New China Life Insurance Co has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does New China Life Insurance Co's YoY EBITDA Growth compare to MET and AFL?
New China Life Insurance Co's YoY EBITDA Growth of 46.24% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for an Insurance company?
A good YoY EBITDA Growth depends on the Insurance industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for New China Life Insurance Co and its competitors. New China Life Insurance Co's current YoY EBITDA Growth is 46.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New China Life Insurance Co stock overvalued right now?
Based on GuruFocus' analysis, New China Life Insurance Co (FRA:NCL) is currently considered Modestly Overvalued. The stock's GF Value™ is €4.61, compared to a current price of €5.15 — trading 11.7% above its estimated fair value. The current YoY EBITDA Growth is 46.24%. New China Life Insurance Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For New China Life Insurance Co (FRA:NCL), the current YoY EBITDA Growth is 46.24% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is New China Life Insurance Co (FRA:NCL) Overvalued in 2026?

Based on GuruFocus' analysis, New China Life Insurance Co stock appears to be overvalued. The current stock price of €5.15 is trading 11.7% above its estimated GF Value™ of €4.61. GuruFocus considers New China Life Insurance Co to be Modestly Overvalued.

Key valuation signals for FRA:NCL:

  • YoY EBITDA Growth: 46.24%
  • GF Value™: €4.61 vs. price of €5.15 (11.7% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the FRA:NCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

New China Life Insurance Co Business Description

Address A12 Jianguomenwai Avenue, New China Insurance Tower, Chaoyang District, Beijing, CHN, 100022
New China Life Insurance Co Ltd is a major Chinese life insurance company headquartered in Beijing, founded in 1996. It provides life insurance, health insurance, accident insurance, and annuity products to individual and group customers across China. The company distributes its products through a multi-channel network that includes a large agency sales force, bancassurance partnerships, group insurance operations, and telemarketing. Premium income from life and health insurance policies forms the core of its revenue, supplemented by investment returns on its substantial insurance fund portfolio. Investment activities are managed through subsidiaries including New China Life Asset Management Company and its Hong Kong-based asset management arm. The company is listed on both the Shanghai Stock Exchange and the Hong Kong Stock Exchange, and it ranks among China's largest life insurers by premiums and total assets.
69GF Score

Get the complete analysis for FRA:NCL

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.15
Price
€4.61
GF Value